The company is operating on a going concern basis. The post Braxia Scientific’s Financial Struggles Overshadow Treatment Successes appeared first on...
TEL AVIV, Israel, Aug. 01, 2023 (GLOBE NEWSWIRE) — The new U.S. patent application is... The post SciSparc and Clearmind Collaboration Continues to Increase...
Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc.... The post Clearmind Medicine Files Patent Application...
The company's financials saw meaningful improvement by most metrics. The post Red Light Holland Sees Rising Revenue, Better Margins in 2023 appeared first...
Bright Minds Biosciences announced the successful completion of its three-part Phase 1 study of BMB-101 The post Bright Minds Biosciences Announces Positive...
PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics The...
Tel Aviv, Israel / Vancouver, Canada, July 17, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc.... The post Clearmind Medicine Announces Share-Based...
Tryp Therapeutics, Inc. (CSE:TRYP / OTCQB:TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active...
Amanita has a long history of use in religious and shamanic rituals in various cultures The post Lucy Scientific Discovery launches sleep aid with Amanita...
Psychedelic drug company Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) has set the date to consolidate its common shares on a five to one basis...